Sustainable East Africa Research in Community Health

NCT01864603 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150395

Last updated 2022-03-02

Study results available
· View outcomes & findings →

Summary

The SEARCH study aims to test evidenced-based innovative community based interventions that lead to the elimination of HIV in rural communities in East Africa using a multi-disease approach. The first phase of the study will quantify the impact of early HIV diagnosis using a streamlined and immediate ART (antiretroviral therapy). The second phase of the study, will quantify the impact of targeted Pre-Exposure Prophylaxis (PrEP) in the context of universal treatment and streamlined care. The study intervention is designed to improve the entire continuum of care, to reduce structural barriers for all populations including those most "at risk".

Conditions

Interventions

OTHER

Universal ART in a streamlined care model

immediate ART start for all HIV+ in community with streamlined care

OTHER

Annual Community Health Campaigns

HIV and multi-disease testing for all community members

OTHER

Targeted PrEP and Targeted testing interventions

OTHER

Baseline community-based HIV and multi-disease testing

HIV and multi-disease testing for all community members at baseline only

Sponsors & Collaborators

  • Infectious Diseases Research Collaboration, Uganda

    collaborator OTHER
  • Makerere University

    collaborator OTHER
  • Kenya Medical Research Institute

    collaborator OTHER
  • Gilead Sciences

    collaborator INDUSTRY
  • World Bank

    collaborator OTHER
  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH
  • United States President's Emergency Plan for AIDS Relief

    collaborator FED
  • Bill and Melinda Gates Foundation

    collaborator OTHER
  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Diane Havlir, MD · University of California, San Francisco

  • Moses Kamya, MBChB, PhD · Makerere University

  • Maya Petersen, PhD · University of California, Berkeley

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • Kenya
  • Uganda

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01864603 on ClinicalTrials.gov